echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > International Journal of Clinical and Health Psychology: Some post-COVID-19 neurological syndrome symptoms may scare yourself

    International Journal of Clinical and Health Psychology: Some post-COVID-19 neurological syndrome symptoms may scare yourself

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The outbreak of COVID-19 constitutes a public health crisis at the international level .


    The neurological deficit may last for a while .
    For example, some patients will experience dizziness, headache, fatigue, and loss of smell for a long time after the initial recovery period .
    This long-term cognitive dysfunction is called Post-COVID-19 Nervous System Syndrome (PCNS) , which has attracted more and more attention from researchers


    COVID-19 The outbreak of COVID-19 constitutes a public health crisis at the international level


    A study by Daniella Winter and Yoram Braw from Ariel University in Israel evaluated the impact of diagnostic threats (i.
    e.
    information about the long-term neurological effects of new coronary pneumonia ) and hints on the recognized symptoms of recovered patients and healthy controls .


    They randomly divided the recovered COVID-19 patients and healthy control groups into a diagnostic threat state (i.


    e.
    , the subject received information about neurological symptoms related to PCNS) and a control state (i.


    They randomly divided the recovered COVID-19 patients and healthy control groups into a diagnostic threat state (i.


    CFQ (Cognitive Impairment Questionnaire) Differences between total groups

    CFQ (Cognitive Impairment Questionnaire) Differences between total groups

    Implied difference in total CFQ score between the diagnostic threat group (n = 155) and the control group (n = 144)

    Implied difference in total CFQ score between the diagnostic threat group (n = 155) and the control group (n = 144)

    Rehabilitation patients (n=90) and healthy controls (n=210) described their cognitive functions after being randomly assigned to the following groups: (a) Experimental group: These participants read an article that discussed Long-term neurological symptoms in survivors of new coronary pneumonia
    .


    (b) Control group: These participants read an article and provide general information about the disease


    Rehabilitation patients (n=90) and healthy controls (n=210) described their cognitive functions after being randomly assigned to the following groups: (a) Experimental group: These participants read an article that discussed Long-term neurological symptoms in survivors of new coronary pneumonia


    Compared with the control group, the patients who recovered under the experimental conditions, rather than the healthy control group, agreed with more symptoms


    COVID-19 Neurological symptoms after COVID-19 may be at least partially affected by non-neural factors such as the threat of diagnosis


    Current research has contributed to diagnostic threats and informative literature by focusing on the current COVID-19 pandemic


    In summary, current research suggests that information about COVID-19 may have clinical significance and, in some cases, may increase subjective neurological complaints due to the harmful effects of diagnostic threats


    Original source

    COVID-19: Impact of diagnosis threat and suggestibility on subjective cognitive complaints.


    https://doi.
    org/10.
    1016/j.
    ijchp.
    2021.
    100253 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.